Fortschritte der Arzneimittelforschung = Progrès des recherches pharmaceutiques.
472 pages
17 hours of reading
Progress in Drug Research is a prestigious book series which provides extensive expert-written reviews on a wide spectrum of highly topical areas in current pharmaceutical and pharmacological research. It serves as an important source of information for researchers concerned with drug research and all those who need to keep abreast of the many recent developments in the quest for new and better medicines.
Volume 41 of "Progress in Orug Research" features eight reviews and various indexes that enhance usability and connect with prior volumes. The articles cover diverse topics, including teratogenesis, nephrotoxicity, bacterial resistance to P. lactam antibiotics, disease eradication through vaccination, chirality in drug design, endogenous digitalis-like factors, erythropoietin, and serotonin (5HT)-antagonists. Each article provides a comprehensive overview of its respective research field. Over its 33-year history, the Editor has benefited from the support and insights of numerous colleagues, with contributions from readers, authors, and reviewers significantly enhancing the series' success. While feedback has generally been positive, it remains essential to evaluate the current status and future trajectory of the review series. The Editor aims to disseminate information across the broad spectrum of drug research, offering readers a means to stay updated on the latest advancements and trends. The reviews are particularly beneficial for non-specialists seeking a quick understanding of specific research areas, while specialists will value the extensive bibliographies and may find new inspiration for their own work.
